Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Gastrointestinal and Cutaneous Pathogenesis in MHC-Mismatched Preclinical Models of Acute and Chronic Graft-Versus-Host Disease

被引：1
|
作者：
Huarte, Eduardo [1 ]
Parker, Melissa [1 ]
Juvekar, Ashish [1 ]
Oliver, Julian [1 ]
Yao, Wenqing [1 ]
Smith, Paul [1 ]
机构：
[1] Incyte Corp, Wilmington, DE USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126749
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5608
引用
收藏
页数：2
相关论文
共 24 条
  • [21] Systemic and local treatment with TG101209, a combined JAK2 and bromodomain BRD4-1 inhibitor, can diminish ocular disease progression in a murine model of graft-versus-host disease
    Mousa, Hazem
    Azar, Nadim S.
    Lin, Liwen
    Komai, Seitaro
    Quiroga-Garza, Manuel
    Ortiz, Ricardo G. Blanco
    Soifer, Matias
    Echegaray, Jose
    Levy, Robert B.
    Perez, Victor L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [22] JAK/Rock Inhibitor TQ05105 for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease: Preliminary Analysis Results of a Phase 1b/2 Study
    Zhao, Yanmin
    Tu, Lifan
    Ye, Yishan
    Luo, Yi
    Shi, Jimin
    Yu, Jian
    Yu, Yi
    Meng, Fankai
    Wang, Tao
    Huang, He
    BLOOD, 2022, 140 : 10505 - 10506
  • [23] A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
    Abboud, Ramzi
    Gao, Feng
    Rettig, Michael P.
    Eisele, Jeremy
    Gehrs, Leah
    Wallace, Nichols
    Abboud, Camille, Sr.
    Westervelt, Peter
    Uy, Geoffrey L.
    Cashen, Amanda F.
    Christopher, Matt
    Ghobadi, Armin
    Jacoby, Meagan A.
    Pusic, Iskra
    Stockerl-Goldstein, Keith E.
    DiPersio, John F.
    Schroeder, Mark A.
    BLOOD, 2021, 138
  • [24] Interim Results of a Pilot, Prospective, Randomized, Double-Blinded, Vehicle- and Comparator-Controlled Trial on Safety and Efficacy of a Topical Inhibitor of Janus Kinase 1/2 (Ruxolitinib INCB018424 Phosphate 1.5% Cream) for Non- Sclerotic and Superficially Sclerotic Chronic Cutaneous Graft-Versus-Host Disease
    Markova, Alina
    Pan, Alexander
    Dusza, Stephen
    Chowdhury, Arifa
    Kukoyi, Oluwaseun
    Perales, Miguel-Angel
    Lacouture, Mario
    Prockop, Susan
    Ponce, Doris M.
    BLOOD, 2021, 138
123